Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical CofiledCriticalSumitomo Chemical Co
Publication of DK129712BpublicationCriticalpatent/DK129712B/da
Application grantedgrantedCritical
Publication of DK129712CpublicationCriticalpatent/DK129712C/da
C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
DK276572A1971-06-041972-06-02Fremgangsmåde til fremstilling af 2,3,4,5-tetrahydro-1H-1,4-benzodiazepinderivater eller syreadditionssalte deraf.
DK129712B
(da)
Analogifremgangsmåde til fremstilling af 3-hydrazonomethyl-rifamycin-derivater eller 25-desacetyl- eller 16, 17, 18, 19, 28, 29-hexahydroderivater deraf.